Brief: Alteogen Signs Licensing Deal With Biogen International For Alt-B4
25/03/2026 07:57
Alteogen Inc 196170.KQ: SIGNS LICENSING DEAL WITH BIOGEN INTERNATIONAL FOR ALT-B4 DEAL WITH BIOGEN CAN GENERATE UP TO $549 MILLION MILESTONES Source text: [ID:] Further company coverage: 196170.KQ
Recent news on Alteogen
See all newsBrief: Alteogen Enters Into A License Agreement With Biogen For Development And Commercialization Of Hybrozyme™-Based Subcutaneous Biologics
Brief: Alteogen Signs Licensing Deal With Biogen International For Alt-B4
Brief: Alteogen 2025 Operating Profit 115 Billion Won, Up 275% From Year Earlier
Brief: Alteogen Signs $285 Million Contract With Gsk Unit
Brief: Alteogen Receives Positive CHMP Opinion For Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'